Villaren, Reighven James S.

HRN: 23-34-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
CEFOTAXIME 500MG (VIAL)
08/15/2023
08/21/2023
IV
85mg
Q6
Neonatal Sepsis
Waiting Final Action 
08/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/15/2023
08/21/2023
IV
50mg
OD
Neonatal Sepsis
Waiting Final Action 
11/15/2023
CEFTRIAXONE 1G (VIAL)
11/15/2023
11/22/2023
IV
640 Mg
Once A Day
PCAP B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: